Back
Maze Therapeutics, Inc. 10K Form
Sell
6
MAZE
Maze Therapeutics, Inc.
Last Price:
$28.72
Seasonality Move:
-7.25%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
10K form not available
Receive MAZE News And Ratings
See the #1 stock for the next 7 days that we like better than MAZE
MAZE Financial Statistics
Sales & Book Value
| Annual Sales: | $0 |
|---|---|
| Cash Flow: | $-27.8M |
| Price / Cash Flow: | 8 |
| Annual Sales: | $7.19 |
| Price / Book: | 4.02 |
Profitability
| EPS (TTM): | -2.84310 |
|---|---|
| Net Income (TTM): | $-131.1M |
| Gross Margin: | $-2.4M |
| Return on Equity: | -44.13% |
| Return on Assets: | -38.65% |
Maze Therapeutics, Inc. Earnings Forecast
Key Maze Therapeutics, Inc. Financial Ratios
-
Per Share Earnings over the last 4 years have been positive in 2 years.
Maze Therapeutics, Inc. Stock Price Chart
Industry, Sector and Symbol
| Stock Exchange: | NASDAQ |
|---|---|
| Industry: | Pharmaceuticals |
| Sector: | Health Care |
| Current Symbol: | MAZE |
| Website: | mazetx.com |
Debt
| Debt-to-Equity Ratio: | 0.07 |
|---|---|
| Current Ratio: | 15.5 |
| Quick Ratio: | 15.16 |
Price-to-Earnings
| Trailing P/E Ratio: | 629.82 |
|---|---|
| Forward P/E Ratio: | 0 |
MAZE Technical Analysis vs Fundamental Analysis
Sell
6
Maze Therapeutics, Inc. (MAZE)
is a Sell
Is Maze Therapeutics, Inc. a Buy or a Sell?
-
Maze Therapeutics, Inc. stock is rated a SellThe current Maze Therapeutics, Inc. [MAZE] share price is $28.71. The Score for MAZE is 6, which is 88% below its historic median score of 50, and infers higher risk than normal.